Clinical trial

Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated…

NCT00383799 · Hospital General Universitario Gregorio Marañon, Other · Terminated

Key facts

NCT number NCT00383799
Title Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia
Official title Comparison of Intravenous Amiodarone Versus Intravenous Procainamide for the Acute Treatment of Regular and Haemodynamically Well Tolerated Wide QRS Tachycardia (Probably of Ventricular Origen). The PROCAMIO Multicenter Study
Lead sponsor Hospital General Universitario Gregorio Marañon, Other
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Ventricular Tachycardia, Wide QRS Tachycardia
Intervention type Drug
Interventions iv Amiodarone, iv Procainamide
Enrollment 302
Start date Sep 1, 2005
Primary completion Jun 1, 2011
Completion Jun 1, 2011
First posted Oct 4, 2006
Last update posted Apr 6, 2016
Countries Spain

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies